Menopause Completed Phase 2 Trials for Oxybutynin (DB01062)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00990886The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal WomenTreatment